Gene · 406943
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in miRNA research: Unraveling the complexities of gene regulation. | Animal Model Exp Med | 2025 | 40947823 | PubTator, text mining | PubMed |
| Implication of microRNA-regulated PTEN expression in the clinico-pathology & survival outcomes in advanced ovarian cancer. | Indian J Med Res | 2025 | 40844103 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma. | Oncol Rep | 2025 | 40776756 | PubTator, text mining | PubMed |
| Targeting the NLRP3-ROS Axis: Disrupting the Oxidative-Inflammatory Vicious Cycle in Intracerebral Hemorrhage. | J Inflamm Res | 2025 | 40735267 | PubTator, text mining | PubMed |
| Regulation and function of microRNA-152 in various types of cancers: its upstream regulators and downstream targets. | Clin Exp Med | 2025 | 40643721 | PubTator, text mining | PubMed |
| The role of non-coding RNA regulates stem cell programmed death in disease therapy. | Noncoding RNA Res | 2025 | 40454168 | PubTator, text mining | PubMed |
| Carotid Plaque-Derived Small Extracellular Vesicles Mediate Atherosclerosis and Correlate With Plaque Vulnerability. | MedComm (2020) | 2025 | 40391195 | PubTator, text mining | PubMed |
| Inflammation-Induced Klotho Deficiency: A Possible Key Driver of Chronic Kidney Disease Progression. | Int J Gen Med | 2025 | 40376197 | PubTator, text mining | PubMed |
| ATF1 and miR-27b-3p drive intervertebral disc degeneration through the PPARG/NF-κB signaling axis. | Commun Biol | 2025 | 40369110 | PubTator, text mining | PubMed |
| Mechanism of microRNA-152 Regulating Decidual Natural Killer Cell Viability and Affecting Trophoblast Cell Invasiveness via the HLA-G/KIR2DL4 Axis. | Kaohsiung J Med Sci | 2025 | 40309956 | PubTator, text mining | PubMed |
| Evaluation of specific lncRNAs, miRNAs, and mRNAs in different groups of prostate cancer. | Bioimpacts | 2025 | 40256234 | PubTator, text mining | PubMed |
| SLC7A5/E2F1/PTBP1/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway. | Cancer Lett | 2025 | 40054655 | PubTator, text mining | PubMed |
| The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets. | Front Immunol | 2024 | 39606232 | PubTator, text mining | PubMed |
| The Toxic Effect of Toluene on Ovarian Cells Can Be Prevented by the MicroRNA miR-152. | Physiol Res | 2024 | 39545793 | PubTator, text mining | PubMed |
| Interplay Between the MicroRNA miR-152 and Quercetin in the Control of Ovarian Granulosa Cell Functions. | Reprod Sci | 2024 | 39476287 | PubTator, text mining | PubMed |
| Retraction: Function of miR-152 as a tumor suppressor in human breast cancer by targeting PIK3CA. | Oncol Res | 2024 | 39308514 | PubTator, text mining | PubMed |
| Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review. | Int J Mol Sci | 2024 | 39273498 | PubTator, text mining | PubMed |
| Upregulation of Serum miR-132 and miR-152 in Vietnamese Patients with Heart Failure. | Malays J Med Sci | 2024 | 39247117 | PubTator, text mining | PubMed |
| Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma. | Int J Mol Sci | 2024 | 39063038 | PubTator, text mining | PubMed |
| Circulating MicroRNA as a Potential Biomarker for Skeletal Disease in Primary Hyperparathyroidism: A Case-control Study. | Ann Surg | 2024 | 38881439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406943/papers?page=2